Total: $197.23M

Company (Symbol)#

Type Of Financing

Number Of Shares, Units Or Warrants (M)

Amount Raised (M)

Investors; Placement Agents;
Details (Date)@

AEterna
Laboratories
Inc. (AELA)

Convertible
term loan facility

N/A

C$25 (US$16.98)

AEterna raised US$16.98M in a convertible term loan facility with investors SGF Sante Inc. and Solidarity Fund QFL (4/1)

Aphton
Corp.
(APHT)

Private
placement of notes and warrants

N/A

$20

Aphton raised $20M in a private placement of convertible 5-year interest-bearing notes and warrants to three institutional investors (4/1)

Biomira
Inc. (Canada;
BIOM;TSE:
BRA)

Private
placement of common stock and warrants

4.8S and
0.815W

$5.5

Biomira raised US$5.5M with the placement of 4.8M shares and up to 814,815 warrants; Rodman & Renshaw Capital Group Inc. acted as exclusive placement agent (4/30)

ChondroGene
Ltd. (Canada;
CDNX:YDG)

Private
placement of common stock

6S

C$3 (US$2.1)

ChondroGene raised US$2.1M through the private placement; Dundee Securities Corp. will act as financial adviser and agent (4/29)

Deltagen
Inc. (DGEN)

Private
placement of preferred stock

N/A

$10

Deltagen raised $10M with the sale of preferred stock convertible into common stock; the financing also includes a bridge loan of $5M (4/4)

DepoMed
Inc. (AMEX:
DMI)

Private
placement of common stock

9.3S

$20

DepoMed raised $20M selling 9.3M shares to accredited investors, including MDS Capital, Hambrecht & Quist Capital Management LLC, HBM BioVentures Ltd., Easton Hunt Capital Partners LP, Special Situations Funds and Quogue Capital LLC (4/22)

EntreMed
Inc. (ENMD)

Private
placement of common stock

4.1S

$10.25

EntreMed raised $10.25M in a private placement with institutional investors (4/25)

Geron Corp.
(GERN)

Private
placement of common stock

4S

$18.4

Geron raised $18.4M with the purchase of 4M shares at $4.60 each by two investors; the investors also received warrants to purchase another 300,000 shares at $6.34 per share; Geron has an option to sell another 400,000 shares at the $4.60 price (4/8)

Matritech
Inc. (NMPS)

Private
placement of convertible debentures and warrants

W for
0.88S

$5

Matritech raised $5M with the sale of 7.5% convertible debentures and warrants to purchase 784,314 shares of common stock at an initial exercise price of $2.27, including warrants to purchase 98,039 shares of common stock issued to a placement agent (4/1)

NeoGenomics Inc. (OTC BB:
NGNME)

Debt financing
through a revolving credit facility

N/A

--

NeoGenomics agreed to sell about 75% of its outstanding common shares to Medical Venture Partners LLC, which will make available up to $1.5M of debt financing through revolving credit (4/16)

Neoprobe
Corp. (OTC
BB: NEOP)

Secured note
financing

N/A

$0.5

Company raised $500,000 in the financing; participants included the company's president and CEO (4/7)

NexMed Inc.
(NEXM)

Private
placement of convertible preferred stock

0.0008S

$8

NexMed raised $8M by selling 800 shares of convertible preferred stock at $10,000 each, with each convertible into about 6,375 shares of common stock (4/22)

The Immune
Response
Corp. (IMNR)

Private
placement of a short-term convertible promissory note

N/A

$2

The Immune Response Corp. raised $2M through the sale of the promissory note to Cheshire Associates LLC (4/1)

Orchid
BioSciences
Inc. (ORCH)

Private
placement of convertible preferred stock

0.0016S

$16

Orchid raised $16M with the sale of 1,600 shares of convertible preferred stock, each convertible into about 22,222 common shares; each preferred share includes a warrant to purchase about 6,667 common shares (4/2)

Procyon
Biopharma
Inc. (Canada;
TSE:PBP)

Private
placement
of units

N/A

C$3.25 (US$2.2)

Procyon raised US$2.2M in a private placement of units at C45 cents per unit; each unit consists of one Procyon common share and about 0.4154 of a warrant; investors were Investissement Desjardins, Societe Innovatech du Grand Montreal and the Fonds regional de solidarite FTQ Laval (4/21)

Rigel Pharma-
ceuticals Inc.
(RIGL)

Private
placement of common stock and warrants

72S and W for 14.4S

$46

Rigel raised $46M through the private placement of 72M shares; investors also will receive warrants to purchase another 14.4M shares; investors were MPM Capital LP, Frazier & Co., Alta Partners and HBM BioVentures AG (4/30)

Viragen
Inc. (AMEX:
VRA)

Credit facility

N/A

$12

Viragen raised $12M as part of a credit agreement with Palisades Master Fund LP (4/1)

Viragen
Inc. (AMEX:
VRA)

Private
placement of secured convertible debentures

N/A

$2.3

Viragen raised about $2.3M in debt financing from a group of its current institutional stockholders (4/30)

Notes:

This chart does not include real estate or manufacturing plant financings.

# Unless otherwise indicated, shares are traded on the Nasdaq exchange.

@ Dates refer to the date of the press release.

N/A = Not available, applicable or reported.

AMEX = American Stock Exchange; CDNX = Canadian Venture Exchange; OTC BB = Over-the-Counter Bulletin Board; TSE = Toronto Stock Exchange